J&J unit says does not intend to bid for Horizon Therapeutics

Johnson & Johnson JNJ unit Janssen Global Services said on Saturday that it does not intend to make an offer for biotech company Horizon Therapeutics Plc (HZNP.O).

Last month, Horizon Therapeutics - which has a market capitalization of about $18 billion - said it was in talks with Amgen Inc AMGN, Sanofi SAN and Janssen Global Services.